| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/25/2004 | CA2498249A1 Ostertagia vaccine |
| 03/25/2004 | CA2498008A1 Novel composition and methods for the treatment of immune related diseases |
| 03/25/2004 | CA2498004A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | CA2498000A1 Use of tumor-associated kinase (task) 110 antagonists for treating pancreatic cancers |
| 03/25/2004 | CA2497801A1 Paks as modifiers of the chk pathway and methods of use |
| 03/25/2004 | CA2497793A1 Flj20647s as modifiers of the p21 pathway and methods of use |
| 03/25/2004 | CA2497790A1 Rors as modifiers of the p21 pathway and methods of use |
| 03/25/2004 | CA2497661A1 Compositions and methods for the diagnosis of immune related diseases using pro71061 |
| 03/25/2004 | CA2497337A1 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | CA2497226A1 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |
| 03/25/2004 | CA2497132A1 Method of diagnosing ovarian endometriosis |
| 03/25/2004 | CA2494274A1 Method and composition for regulating the activity of regulatory t cells |
| 03/25/2004 | CA2494216A1 Use of dendritic cells (dcs) expressing interleukin 12 (il-12) |
| 03/25/2004 | CA2484339A1 Method for isolating hepatitis c virus peptides |
| 03/24/2004 | EP1400592A1 Streptococcus pneumoniae polynucleotides and sequences |
| 03/24/2004 | EP1400591A1 Agent for treatment of exocrine gland disorders and transgenic mouse useful for screening the same |
| 03/24/2004 | EP1400536A1 Method for making humanized antibodies |
| 03/24/2004 | EP1400532A1 M. paratuberculosis specific ABC-transporter operon |
| 03/24/2004 | EP1400174A1 Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk |
| 03/24/2004 | EP1399850A2 Hla ligand database utilizing predictive algorithms and methods of making and using same |
| 03/24/2004 | EP1399740A2 Type 1 diabetes diagnostics and therapeutics |
| 03/24/2004 | EP1399739A2 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 03/24/2004 | EP1399593A2 Genes expressed in breast cancer as prognostic and therapeutic targets |
| 03/24/2004 | EP1399584A2 Cancer-linked genes as targets for chemotherapy |
| 03/24/2004 | EP1399583A2 Compositions and methods relating to breast specific genes and proteins |
| 03/24/2004 | EP1399579A1 Fkbp51/52 and cyp40-mediated mammalian hair growth |
| 03/24/2004 | EP1399578A2 Adsls as modifiers of the p53 pathway and methods of use |
| 03/24/2004 | EP1399574A2 Improved vectors for gene therapy |
| 03/24/2004 | EP1399570A2 Peptides for use as translocation factors |
| 03/24/2004 | EP1399563A2 Moraxella (branhamella) catarrhalis antigens |
| 03/24/2004 | EP1399558A2 Vanilloid receptor-related nucleic acids and polypeptides |
| 03/24/2004 | EP1399556A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 03/24/2004 | EP1399552A2 G-protein coupled receptor proteins (gpcr) and nucleic acids encoding same |
| 03/24/2004 | EP1399549A1 Anticomplement polypeptide from salivary glands of the tick ixodes ricinus |
| 03/24/2004 | EP1399540A2 Continuous, normal human t-lymphocyte cell lines comprising a recombinant immune receptor with defined antigen specificity |
| 03/24/2004 | EP1399483A2 Antibodies to insulin-like growth factor i receptor |
| 03/24/2004 | EP1399482A2 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 03/24/2004 | EP1399478A2 Cancer-testis antigens |
| 03/24/2004 | EP1399476A1 Use of soluble cytokeratine-1-fragments in diagnostics and therapy |
| 03/24/2004 | EP1399426A2 Compounds, compositions and methods for modulating beta-amyloid production |
| 03/24/2004 | EP1399215A2 Tissue-specific endothelial membrane proteins |
| 03/24/2004 | EP1399203A1 Nasal drug delivery devices |
| 03/24/2004 | EP1399186A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein |
| 03/24/2004 | EP1399185A2 Use of polyclonal immunoglobulins as vaccine |
| 03/24/2004 | EP1399184A2 Uses of mammalian genes and related reagents |
| 03/24/2004 | EP1399182A2 Papillomavirus vaccines |
| 03/24/2004 | EP1399181A2 Peptide vaccines against group a streptococci |
| 03/24/2004 | EP1399175A2 Therapeutic use of rank antagonists |
| 03/24/2004 | EP1399168A1 Xenogenic oligoor/and polyribonucleotides as agents for the treatment of malignant tumours |
| 03/24/2004 | EP1399162A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| 03/24/2004 | EP1399131A2 Spray freeze-dried compositions |
| 03/24/2004 | EP1399110A2 Antibodies abolish prion propagation and promote clearance of infectivity |
| 03/24/2004 | EP1150693B1 Immunogenic compositions for use as vaccines |
| 03/24/2004 | EP0946592B1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 03/24/2004 | EP0869970B1 Endothelial cell proliferation inhibitor and its use |
| 03/24/2004 | EP0869773B1 Archaeosomes, archaeosomes containing coenzyme q 10, and other types of liposomes containing coenzyme q 10 as adjuvants and as delivery vehicles |
| 03/24/2004 | EP0796277B1 Fusion junction type iii mutant egf receptor peptide tumour vaccine |
| 03/24/2004 | EP0784469B1 Compositions for the delivery of antigens |
| 03/24/2004 | EP0625212B1 Methods of detecting alzheimer's disease |
| 03/24/2004 | CN1484700A Aop beta gene protein homologs fragments and thereof and their use for cell surface display |
| 03/24/2004 | CN1484699A Novel mutant allergens |
| 03/24/2004 | CN1484652A Antibodies to human IL-1 beta |
| 03/24/2004 | CN1484650A Urocortin proteins and uses thereof |
| 03/24/2004 | CN1484532A Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens |
| 03/24/2004 | CN1484531A Preparation process for combined vaccine |
| 03/24/2004 | CN1483812A M. smegmatics vaccine |
| 03/24/2004 | CN1483736A Immunogen for producing vaccine or medicine to treat hepatitis B, its preparation process and use |
| 03/24/2004 | CN1483477A Vaccin composition, preparation method and use thereof |
| 03/24/2004 | CN1483476A Process for preparing antitoxin toxinicide |
| 03/24/2004 | CN1483475A Combined bacterin for treating allergic disease and preparation method |
| 03/24/2004 | CN1142772C Lipophilic microparticles containing protein drug or antigen and formulation comprising same |
| 03/23/2004 | US6710226 Administering agent to induce immune response against amyloid deposit; drug screening, vaccines |
| 03/23/2004 | US6710172 Tumor antigens and CTL clones isolated by a novel procedure |
| 03/23/2004 | US6710171 Isolated dna encoding protein having specified amino acid sequence; treating or preventing arteriosclerosis and restenosis after treatment of artery occlusion |
| 03/23/2004 | US6710166 Isolated rcp41 protein comprising specified amino acid sequence; antigenic and effective to elicit immune response against cryptosporidium parvum in host animal |
| 03/23/2004 | US6710026 Diabetes |
| 03/23/2004 | US6709851 Stabilization of helicobacter urease |
| 03/23/2004 | US6709842 DNA encoding a growth factor specific for epithelial cells |
| 03/23/2004 | US6709841 Generating preferential polypeptide; obtain cell, transform with vector coding preferential polypeptide, recover polypeptide |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709830 Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation |
| 03/23/2004 | US6709679 Antineoplastic conjugates of transferin, albumin and polyethylene glycol |
| 03/23/2004 | US6709672 Generating protein complexes for use in the treatment of immunological defects; obtain sample, hydrolyze, incubate with binding protein, recover composition comprising peptides bound to chaperone proteins |
| 03/23/2004 | US6709661 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 03/23/2004 | US6709660 Meningococcal antigens |
| 03/23/2004 | US6709658 Pneumococcal vaccines formulated with interleukin-12 |
| 03/23/2004 | US6709657 Includes immunogenic fragment of at least 15 amino acids matching aligned contiguous segment of sequence 2 |
| 03/23/2004 | US6709656 Polyclonal and/or monoclonal immunoglobulin immunization |
| 03/23/2004 | US6709654 Treatment of psoriasis using anti-B7.1 (CD80) antibodies |
| 03/23/2004 | US6709649 RANTES derived peptides with anti-HIV activity |
| 03/18/2004 | WO2004022768A1 Arachidonic acid metabolites and modulation of mitosis and apoptosis of cells |
| 03/18/2004 | WO2004022762A1 Orthopoxvirus vectors, genes and products thereof |
| 03/18/2004 | WO2004022760A1 Generation of recombinant influenza virus using baculovirus delivery vector |
| 03/18/2004 | WO2004022752A1 Smg-1-binding protein and method of screening substance controlling its activity |
| 03/18/2004 | WO2004022729A1 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 03/18/2004 | WO2004022724A2 Adoptive transfer and uses thereof |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022709A2 Epitope sequences |
| 03/18/2004 | WO2004022657A2 Increasing of the resorption of substances via skin and mucous membranes |
| 03/18/2004 | WO2004022596A1 Monoclonal antibody against adiponectin, preparation method and use thereof |